Evaluation of Behaviour in Parkinson's Disease. Normal Values in Healthy Subjects
NCT ID: NCT02820428
Last Updated: 2016-07-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
124 participants
INTERVENTIONAL
2009-04-30
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Due to their specificity and the absence of an appropriate evaluation tool, behavioral disorders are rarely searched for.
Therefore, investigators developed a scale permitting qualitative and quantitative evaluation of behavior according to the severity of the disorders.
This study aims to define reference values for healthy individuals
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Electroencephalographic Signatures of Neuropsychiatric Fluctuations in Parkinson's Disease
NCT06301282
Evaluation of Dysfunction of the Basal Ganglia Before a Parkinsonian Walking in the Elderly: Risk of Falling and Confusional State
NCT02885493
Social Cognition Dysfunctions in Parkinson's Disease
NCT05230095
Validation of a Diagnostic Self-assessment Scale Non-motor Fluctuations at the Parkinson's Patient
NCT02859805
Evaluation of Clinical Perfectionism in Parkinson Disease
NCT02824367
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The ECMP scale consists of 21 items, each of which may be assessed by use of a 5 point scale (not at all - light trouble - moderate trouble - important trouble - severe trouble)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy participants
Submission of the scale 'Evaluation of behaviour in Parkinson's Disease' to healthy subjects
Healthy participants
Semi-structured interview
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Healthy participants
Semi-structured interview
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Men and women from 25 to 75 years old
* French mother tong
* without cognitive troubles (MMS ≥ 24)
Exclusion Criteria
* Pregnant woman or with childbearing potential without contraceptive device
25 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Grenoble
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anna Castrioto, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Grenoble
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2009-A00103-54/3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.